Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

Clinical trial NCT04593927 · COMPLETED

Trial details

NCT number: NCT04593927
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Secondary Progressive Multiple Sclerosis (SPMS)

Start date: 2020-10-28
Primary completion: 2023-08-30
Enrollment: 451

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.